US TOP 100

Large cap

Listing information NYSE Healthcare

CEO José Alme1 da

CFO Cha rles Dockendorf f

Head of IR Coleman Lannum

IRteam Tod d C arpenter, Ann Broughton

IR team size

Three

IR awards

Gra nd pr1x f or bes t overa ll invest or relati ons program - large cap

Bes t 1nve stor rela t10ns off1 cer - large cap Bes t IR by a C EO or c hairman - larg e cap Bes t 1nvestment c ommun1 ty meetmgs

Bes t 1nve stor rela t10ns dur1ng a corporale transac t10n

Bes t 1 n sector- healthcare

Contact information www.cov1 d1 en.com

cole.lannumlclcov1 d1 en.com l +1 508 452 4343

Rank 2013: 1

'C ovi d1en i s always on the roa d getting in front of people, w1 th the C EO a nd CFO ever -present, a nd i t hos t s the most frequent and best - presen t ed mvestor days. The head of IR has a buy- s1de background, wh1ch 1 s use f ul' - buy s1 de

'Cov1 d1 en cons1s tently commun1 cates w1th the Stree t , whether the news 1 s pos1 t1 ve or negative' - sell s1 de

'There are very few surpri ses wi th Cov1di en, as i t rea ehes out t o us a nd makes sure we are well prepared , and t ha t reduces uncertam ty. The IR t eam g1 ves ou t a very clear message' - sell s1de

Equal treatment

t's another year a t the t op o f t he pile f or medica l equi pmen t supp lier Covidi en, as 2014 marks t he

US Top

H e a dds t ha t t he rot a tlona l program 1s somet h1ng that i s supported a t the execut1 ve level a t Covid1en, and

that t he IR pos1 t ion 1 s treated as a 'cheri shed role ' in any

company's f ourth year in pole posi t1 on 1 n the

100. Of the ni ne awards 1t i s nomi nat e d f or th1s year, Cov1dien walks away with six - double l ast year's t a lly

- 1ncluding t he covet ed grand prix for best overa ll

1nvest or rel a tlons at a large- cap company.

lt's also t he f ourth year 1 n a row that Cole Lannum, the company's hea d o f 1 nvest or rel a ti ons of e1 gh t years, has been named as t he best IR prof ess1 ona l at a l arge cap. His close-kn 1t, t hree- person team 1 ncludes an admi n1strative assist ant and a rot a ti ng seni or di rect or

o f I R. 'l expect to have h 1 m around f or another si x to

12 mon ths before ll ose h 1 m t o b 1 gger and bett er thi ngs 1n t he organiza t1on,' muses Lannum.

young execut1ve's f orma t1ve years. 'it's unusua l1n a lot of d 1 fferent ways f or an up- and- comi ng career-minded person to come and learn I R for two or threeyears,

and t o get unprecedent ed exposure t o t he seni or

managemen t t eam and t he board,' he expla 1 ns.

The s upport from above, Lannum con tinues, is keenly felt 1 n IR : Covid1en's C FO, Charles Oockendorff ,

is nomina ted f or t he award f or best IR by a CFO , and the fwm's CEO José Al me1da w1ns t h1s year's award for best CEO f or I R among large-cap US compan1es. 'They get i t when 1t comes to underst and1 ng t he 1 mportance of t he investmen t community as a constituency, and t he1r roles

IR MAGAZINE I NVESTOR PERCEPTION STU OY - US 2014 Il

US TOP 100

l 561 Covidien

l 454 lntel

Honeywell

Johnson & Johnson NextEra Energy Texas lnstruments

American Express

Southern Company

TimeWarner

JPMorgan Chase & Co

Grand pnx for best overall rnvestor relatrons program - large cap

long -t erm projects. Sen r or management r s mr ndf ul of what 1nvest ors think about t he company and wa nt to happen, Lannum notes, and I R is used to info rm

hrgh-levelportfo lio and st rate gy meetings as a matter o f

necess1ty. 'The flrp -s i de 1 s that th1 s allows me t o speak as someone wrth authorrty when answerr ng rnvest ors' questi ons,· Lannum con tinues. 'Knowledge o f a long ­ term proJect, f or example, a llows me to shape my answers a b 1t more appropria tely and respond we ll.'

Fo r Lan num, 2013 proved to be a yea r f o r cons is­

tency, not only when 1t came t o ma1nta1ning h1s f1rm's hrgh IR standards, but also for shap 1ng the way in whr c h he and his tea m int era e t w1th each 1nvest or: We thin k of the ent1re investment co mmun1ty, agnostr cally,' Lannum expands. Whe ther l've got someone l've never heard

f rom before w ho runs $10 mn of asset s, or Fidelity or

Cap1ta lResearch or the Governmen t of Si ngapore or a ret a rlrnvest or before me , we try t o t reat them allrn exactly the sa me way. lf you' re 1nterested 1 n a p ieee

of 1nformat ion on what we have, l d on't think it's my

jo b t o t ry to JU dge what kind of 1nvesto ryou are

As a result, Covr dien's team members do n't spend an undue amount of trme o n sharehold er target1ng but t ry t o mainta1n a mutua lapprec i atr on fo r each other's

- and co nstituents'- ti me. The reality 1 s, Lannum a dds,

1n communicat1ng with 1t, ' expl ain s Lannum.

Equally imp o rt ant , however, 1 s the understanding tha t IR r s Lannum's ultimate responsr b ility, and though Dockendorff and A lmeida are involved, neither 1 s a

m r cro -manager: 'They let me handle I R andare available

when needed, but they stay out o f myway an d let me deal with the day-t o -day function1ng of things,· Lannum says. 'l thr nk the rel a ti on shrp works out rea llywe ll because of that c omb inatr on

The oth er s ide of th1 s relat1 onship means I R has become st ra t e gica l ly f ar more important a t Covidr en, where 1t has become 'entwi ned ' wit h the company's wider strat egy, bus1ness development and other

Covidien

Sprn- o ff of lv1allr nckro dt Pharamceut r cals, June 201

21st Century Fox

Splrt t o f orm 21st Cent ury Fox an d N ews Corp Publr shr ng

PVH Corporation

Acqursr tion o f Warnaco Group, February 2013

Actavis

Acqur sr t i on o f Warner Chilcot t, Oc t ober 201 3

Dynegy

Acqur srtr on of Ameren Energy Resources, O ecember 2013

L Brands

Johnson & Johnson

Southern Company

Anadarko Petroleum

United Technologies

UnitedHealth Group

21st Century Fox

Covidien

Best rnvestment communrty meetrngs

m I R MAGAZINE INVESTOR PERCEPT I O N STUOY- US 2014

Tex:as lnstruments

Ron 51aymaker

Honeywell

ElQna Ooom

Ba er lnternational

Mary Kay Ladone

Colgate-Palmolive

Bina Thompson

UnitedH ealth Group

John Penshom

Illinois Tool Works

John Brooklier

Proctter & Gamble

John ChEWaliQr

Johnson & John son

US TOP 100

Covidien

Co!Qman Lannum


thatiR is a U/7 job. 'Panicularly when portfolio managers or analysts are trying to make a decision and need a few facts to help them, if l'm the only one in the way of them coming t o a conclusion then they're going
t o appreciate a quick and accurate response,' he explains. 'lf l'm on the phone at 8.00 pm on a Sunday night, it's because an event has happened, something is going on and my constituent s need answers.'
This involves a busy travelprogram, during which
Lannum est imat es his team panicipates in 40-45 IR events annually. 'lf you exclude earnings and holidays, it works out at about one invest or event a week, fNery week, over the past five years,' he calculates. These ext end from multiple investor days and events at Covidien·s plants and organizations around theworld
t o non-dealroadshows and investor conferences.
'lt's really across the board,' Lannum summarizes.
Covidien·s shareholder base requires this kind of attention, however. Lannum describes his company's holding as 'widely institutional' among a fairly smallpool of investors. Over the last few years, 'we·ve seen an uptick in western European ownership,' he notes. As an lrish public limit ed company - officially based in Dublin
- Covidien enjoys many European investment firms holding a st ake in the business, while US-only funds can also benefit from its NYSE listing. 'We didn't design the company to appealt o so many different organizations,'
jokes Lannum. 'lt's just a fringe benefit of the way wùe structured.' Because of this, Covidien's management
holds four to five board meetings in Dublin annually, and can jump across to mainland Europe fora few roadshows atthe same time.
One fNentthat dominated Covidien's 2013 was completing the spin-off of its dedicated pharmaceuticals business, Mallinckrodt, into a listed entity in its own
right. After months of pianning, the business was finally spun off and trading opened on July 1, 2013. Even
though Mallinckrodt was wellknown in the specialist
pharmaceuticalindustry, Lannum describ es the process as one of investor education. To that end, bolstered with a new IRO hired just forthetask, the spun-off business' relatively new CEO and CFOwere broughtto a number
of meet-and-greet event s and generally made available to inquisitive investors.
'We had t o make sure they had a platform early,
while they were stili part of Covidien, so they could settheir own communication objectives ortheir own meetings,' Lannum explains. Severalquaners before the spin-off itself - in late 2012 and early 2013 - Mallinckrodt's lR contingent was meeting invest ors on
non-dealroadshows and at sell-side conferences, while
the firm's CEO was meeting with investors one-to-one

IR MAGAZINE INVE5TOR PERCEPTION 5TUDV- U5 2014 111

US TOP 100

and answering t he1r questlons. Lannum, meanwhile, wa ited in the wings as an observer, both t o help and

t o f ulf1 l ld1sclosure requirement s.

New 1nvesto rs were a lso g1ven an extens1ve

s harehol der deck co mpi led f rom bot h co mpan1es, produced t o be above and bey ond SEC requwements, and bursting w1th a comple te history of both companies and a comprehensive v1ew of the numbers involved.

'We put o u r heads together and tho ught abo ut what we

wo uld nee d to make an appropnate va luation dec1s1on

1f we had never heard of the company before,' Lannum

recalls. The eff o rt was apprec1a t e d by 1nvestors, and named by so many as a modelf or I R undertaken duri ng a corporate transac ti o n tha t Covid1en p1cked up another l R Magaz1ne Award f or the way it commu nica ted w1th invest ors during t he sp1n-off.

In light of s uch a busy 2013, what are Lannum's

plans f or 2014? 'Noth1ng really earth-sha king,' he replies. 'l th1nk 1t's go1ng t o be much the sa me as w ha t you've seen 1n the past . We may be t weaking some of the event s we do, but fundamentally we're go1ng to

rema1n focused on wha t people are really int erested In.·

THE VIEW FROM THE TOP

lnterviewwith José Almeida, chairman of the board, president and CEO at Covidien

What did you feelwas the most important thing to communicate to investors in 2013?

The spin-off of our Mallinckrodt business was a big event for us this year and IR communications were critical. Additionally, i t has been important for us to communicate about our agility in responding to the changing healthcare landscape. Ongoing shifts in healthcare are putting pressure on the entire industry and it is important for investors to understand how

our strategy positions us to grow and drive shareholder

value in the face of these changes. We are also seeing success in our investments in emerging markets where we are growing above the market in key areas, including more than 25 percent growth last year in Brazil, Russia, India and China.

Finally, our commitment to return on invested

capitaiand capitai deployment has been a major focus area. We remain committed to using our strong cash flow to fund business expansion, while returning at least 50 percent of our free cash flow to shareholders through dividends and share repurchases. We returned more than 130 percent of our free cash flow to shareholders last year.

What do you enjoy most about your role in IR?

llike hearing from the very smart people who follow our company. l am always learning and our investment community helps teach me many things about our business from an outsider's point of view.

Why is IR treated with such importance at Covidien? All of our constituencies are important and that certainly includes investors. We believe differentiated IR can add value over time: from day one when we

Il IR MAGAZINE INVESTOR PERCEPTI ON STUDY- US 2014

spun off as an independent company in 2007, we have viewed IR as a differentiator and have focused on i t.

l believe a superior investor relations function enables our seni or team to spend more time on running the company. One of the advantages of having a highly effective IR team is that l trust it to do much

of the day-to-day communication, so neither l nor one

of my senior operating managers is required to be present for every single meeting.

How would you describe the IR philosophy at Covidien in three words?

Transparent, credible and responsive.

Covidien

José Alme tda

CBS

Lesl1 e Moonves

Danaher

Lawrence Culp

Honeywell

Dav1d Cote

Precision Castparts Corp

Mark Donegan

Duke Energy

Lynn Good

UnitedHealth Group

St ephen H emsley

JPMorgan Chase & Co

Jam1e D1mon

McKesson

John Hamm ergren

The Coca-Cola Company

Muhtar Kent

Best l R by a CEO or cha1 rman - large ca

distributed by